Correlation Between Verizon Communications and Rakovina Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verizon Communications and Rakovina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verizon Communications and Rakovina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verizon Communications CDR and Rakovina Therapeutics, you can compare the effects of market volatilities on Verizon Communications and Rakovina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verizon Communications with a short position of Rakovina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verizon Communications and Rakovina Therapeutics.

Diversification Opportunities for Verizon Communications and Rakovina Therapeutics

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Verizon and Rakovina is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Verizon Communications CDR and Rakovina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rakovina Therapeutics and Verizon Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verizon Communications CDR are associated (or correlated) with Rakovina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rakovina Therapeutics has no effect on the direction of Verizon Communications i.e., Verizon Communications and Rakovina Therapeutics go up and down completely randomly.

Pair Corralation between Verizon Communications and Rakovina Therapeutics

Assuming the 90 days trading horizon Verizon Communications CDR is expected to under-perform the Rakovina Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Verizon Communications CDR is 8.87 times less risky than Rakovina Therapeutics. The stock trades about -0.42 of its potential returns per unit of risk. The Rakovina Therapeutics is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  12.00  in Rakovina Therapeutics on October 10, 2024 and sell it today you would earn a total of  5.00  from holding Rakovina Therapeutics or generate 41.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Verizon Communications CDR  vs.  Rakovina Therapeutics

 Performance 
       Timeline  
Verizon Communications 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verizon Communications CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Rakovina Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Rakovina Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Rakovina Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Verizon Communications and Rakovina Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verizon Communications and Rakovina Therapeutics

The main advantage of trading using opposite Verizon Communications and Rakovina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verizon Communications position performs unexpectedly, Rakovina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rakovina Therapeutics will offset losses from the drop in Rakovina Therapeutics' long position.
The idea behind Verizon Communications CDR and Rakovina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Content Syndication
Quickly integrate customizable finance content to your own investment portal
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format